RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.
|Poll|June 19, 2015
Mini Quiz: Dementia
Author(s)Psychiatric Times Editors
What is the most common problem in individuals with dementia?
Advertisement
What is the most common problem in individuals with dementia?
Advertisement
Related to this article
Learn why SSRIs impair sex and how bupropion, PDE5 inhibitors, buspirone, and newer agents can prevent or reverse antidepressant sexual side effects.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
3
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
4
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
5